table of content
1 Introduction to Research & Analysis Reports
1.1 Transmucosal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transmucosal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transmucosal Drug Delivery Overall Market Size
2.1 Global Transmucosal Drug Delivery Market Size: 2021 VS 2028
2.2 Global Transmucosal Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transmucosal Drug Delivery Players in Global Market
3.2 Top Global Transmucosal Drug Delivery Companies Ranked by Revenue
3.3 Global Transmucosal Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Transmucosal Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Transmucosal Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transmucosal Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Transmucosal Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Transmucosal Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Passive Transdermal Drug Delivery
4.1.3 Active Transdermal Drug Delivery
4.2 By Type - Global Transmucosal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Transmucosal Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Transmucosal Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transmucosal Drug Delivery Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Transmucosal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Transmucosal Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Transmucosal Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Transmucosal Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Transmucosal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Transmucosal Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Transmucosal Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Transmucosal Drug Delivery Revenue, 2017-2028
6.3.2 US Transmucosal Drug Delivery Market Size, 2017-2028
6.3.3 Canada Transmucosal Drug Delivery Market Size, 2017-2028
6.3.4 Mexico Transmucosal Drug Delivery Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Transmucosal Drug Delivery Revenue, 2017-2028
6.4.2 Germany Transmucosal Drug Delivery Market Size, 2017-2028
6.4.3 France Transmucosal Drug Delivery Market Size, 2017-2028
6.4.4 U.K. Transmucosal Drug Delivery Market Size, 2017-2028
6.4.5 Italy Transmucosal Drug Delivery Market Size, 2017-2028
6.4.6 Russia Transmucosal Drug Delivery Market Size, 2017-2028
6.4.7 Nordic Countries Transmucosal Drug Delivery Market Size, 2017-2028
6.4.8 Benelux Transmucosal Drug Delivery Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Transmucosal Drug Delivery Revenue, 2017-2028
6.5.2 China Transmucosal Drug Delivery Market Size, 2017-2028
6.5.3 Japan Transmucosal Drug Delivery Market Size, 2017-2028
6.5.4 South Korea Transmucosal Drug Delivery Market Size, 2017-2028
6.5.5 Southeast Asia Transmucosal Drug Delivery Market Size, 2017-2028
6.5.6 India Transmucosal Drug Delivery Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Transmucosal Drug Delivery Revenue, 2017-2028
6.6.2 Brazil Transmucosal Drug Delivery Market Size, 2017-2028
6.6.3 Argentina Transmucosal Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, 2017-2028
6.7.2 Turkey Transmucosal Drug Delivery Market Size, 2017-2028
6.7.3 Israel Transmucosal Drug Delivery Market Size, 2017-2028
6.7.4 Saudi Arabia Transmucosal Drug Delivery Market Size, 2017-2028
6.7.5 UAE Transmucosal Drug Delivery Market Size, 2017-2028
7 Players Profiles
7.1 3M Pharmaceuticals
7.1.1 3M Pharmaceuticals Corporate Summary
7.1.2 3M Pharmaceuticals Business Overview
7.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Major Product Offerings
7.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.1.5 3M Pharmaceuticals Key News
7.2 Acrux Limited
7.2.1 Acrux Limited Corporate Summary
7.2.2 Acrux Limited Business Overview
7.2.3 Acrux Limited Transmucosal Drug Delivery Major Product Offerings
7.2.4 Acrux Limited Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.2.5 Acrux Limited Key News
7.3 ALZA Corporation
7.3.1 ALZA Corporation Corporate Summary
7.3.2 ALZA Corporation Business Overview
7.3.3 ALZA Corporation Transmucosal Drug Delivery Major Product Offerings
7.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.3.5 ALZA Corporation Key News
7.4 Antares Pharma, Inc.
7.4.1 Antares Pharma, Inc. Corporate Summary
7.4.2 Antares Pharma, Inc. Business Overview
7.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Major Product Offerings
7.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.4.5 Antares Pharma, Inc. Key News
7.5 Apricus BioSciences, Inc
7.5.1 Apricus BioSciences, Inc Corporate Summary
7.5.2 Apricus BioSciences, Inc Business Overview
7.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Major Product Offerings
7.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.5.5 Apricus BioSciences, Inc Key News
7.6 Aveva Drug Delivery Systems
7.6.1 Aveva Drug Delivery Systems Corporate Summary
7.6.2 Aveva Drug Delivery Systems Business Overview
7.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Major Product Offerings
7.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.6.5 Aveva Drug Delivery Systems Key News
7.7 Corium International, Inc
7.7.1 Corium International, Inc Corporate Summary
7.7.2 Corium International, Inc Business Overview
7.7.3 Corium International, Inc Transmucosal Drug Delivery Major Product Offerings
7.7.4 Corium International, Inc Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.7.5 Corium International, Inc Key News
7.8 DURECT Corporation
7.8.1 DURECT Corporation Corporate Summary
7.8.2 DURECT Corporation Business Overview
7.8.3 DURECT Corporation Transmucosal Drug Delivery Major Product Offerings
7.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.8.5 DURECT Corporation Key News
7.9 Generex Biotechnology Corporation
7.9.1 Generex Biotechnology Corporation Corporate Summary
7.9.2 Generex Biotechnology Corporation Business Overview
7.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Major Product Offerings
7.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.9.5 Generex Biotechnology Corporation Key News
7.10 Inovio Pharmaceuticals, Inc.
7.10.1 Inovio Pharmaceuticals, Inc. Corporate Summary
7.10.2 Inovio Pharmaceuticals, Inc. Business Overview
7.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.10.5 Inovio Pharmaceuticals, Inc. Key News
7.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
7.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Corporate Summary
7.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
7.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Major Product Offerings
7.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Key News
7.12 MedPharm LTD
7.12.1 MedPharm LTD Corporate Summary
7.12.2 MedPharm LTD Business Overview
7.12.3 MedPharm LTD Transmucosal Drug Delivery Major Product Offerings
7.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.12.5 MedPharm LTD Key News
7.13 Mylan, Inc.
7.13.1 Mylan, Inc. Corporate Summary
7.13.2 Mylan, Inc. Business Overview
7.13.3 Mylan, Inc. Transmucosal Drug Delivery Major Product Offerings
7.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.13.5 Mylan, Inc. Key News
7.14 Nemaura Pharma Ltd
7.14.1 Nemaura Pharma Ltd Corporate Summary
7.14.2 Nemaura Pharma Ltd Business Overview
7.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Major Product Offerings
7.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.14.5 Nemaura Pharma Ltd Key News
7.15 Nitto Denko Corporation
7.15.1 Nitto Denko Corporation Corporate Summary
7.15.2 Nitto Denko Corporation Business Overview
7.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Major Product Offerings
7.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.15.5 Nitto Denko Corporation Key News
7.16 Noven Pharmaceuticals, Inc.
7.16.1 Noven Pharmaceuticals, Inc. Corporate Summary
7.16.2 Noven Pharmaceuticals, Inc. Business Overview
7.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.16.5 Noven Pharmaceuticals, Inc. Key News
7.17 Pantec Biosolutions AG
7.17.1 Pantec Biosolutions AG Corporate Summary
7.17.2 Pantec Biosolutions AG Business Overview
7.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Major Product Offerings
7.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.17.5 Pantec Biosolutions AG Key News
7.18 Tapemark
7.18.1 Tapemark Corporate Summary
7.18.2 Tapemark Business Overview
7.18.3 Tapemark Transmucosal Drug Delivery Major Product Offerings
7.18.4 Tapemark Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.18.5 Tapemark Key News
7.19 tesa Labtec GmbH
7.19.1 tesa Labtec GmbH Corporate Summary
7.19.2 tesa Labtec GmbH Business Overview
7.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Major Product Offerings
7.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.19.5 tesa Labtec GmbH Key News
7.20 TEVA Pharmaceutical Industries Ltd.
7.20.1 TEVA Pharmaceutical Industries Ltd. Corporate Summary
7.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
7.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Major Product Offerings
7.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.20.5 TEVA Pharmaceutical Industries Ltd. Key News
7.21 Zosano Pharma
7.21.1 Zosano Pharma Corporate Summary
7.21.2 Zosano Pharma Business Overview
7.21.3 Zosano Pharma Transmucosal Drug Delivery Major Product Offerings
7.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.21.5 Zosano Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
